2005Journal of Heze Medical CollegeRequires access

Eeffect of Tongxinluo Capsule on Blood Lipid in Patients with Coronary Disease

Qing Zhang

Open publisher page 0 citations

Abstract

Objective To observe the effects of Tongxinluo Capsule on blood lipid in patients with coronary disease and hyper-lipoproteinemia . Methods Sixty patients with coronary disease and hyperlipoproteinemia were divided into trial group (n=30) and control group(n= 30) randomly, basal treatment were given to both group. The trial group was treated with Tongxinluo Capsule 4 capsules 3 times a day. Changes of blood lipid and clinical symptom were observed after treatment for 4 weeks. Results Compared with the control group, after patients had been treated with Tongxinluo Capsule for 4 weeks, sinificant improvement was shown in lipid abnormality.The levels of total cholesterol,riglyceride,low density lipoprotein cholesterol,apo- lipoprotein B (ApoB), lipoprotein(a),lowered and ApoA/ApoB ratio increased observiously. The effect of both remedies in elevating HDL - C was similar. Conclusion Tongxinluo Capsule had definite regulatory effect on the blood lipids and lipoproteins in patients with coronary disease and hyperlipoproteinemia

About this research paper

What this paper is about

Objective To observe the effects of Tongxinluo Capsule on blood lipid in patients with coronary disease and hyper-lipoproteinemia . Methods Sixty patients with coronary disease and hyperlipoproteinemia were divided into trial group (n=30) and control group(n= 30) randomly, basal treatment were given to both group. The trial group was treated with Tongxinluo Capsule 4 capsules 3 times a day. Changes of blood lipid and clinical symptom were observed after treatment for 4 weeks. Results Compared with the control group, after patients had been treated with Tongxinluo Capsule for 4 weeks, sinificant improvement was shown in lipid abnormality.The levels of total cholesterol,riglyceride,low density lipoprotein cholesterol,apo- lipoprotein B (ApoB), lipoprotein(a),lowered and ApoA/ApoB ratio increased observiously. The effect of both remedies in elevating HDL - C was similar. Conclusion Tongxinluo Capsule had definite regulatory effect on the blood lipids and lipoproteins in patients with coronary disease and hyperlipoproteinemia

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of Tongxinluo Capsule on blood lipid in patients with coronary disease and hyper-lipoproteinemia . Methods Sixty patients with coronary disease and hyperlipoproteinemia were divided into trial group (n=30) and control group(n= 30) randomly, basal treatment were given to both group. The trial group was treated with Tongxinluo Capsule 4 capsules 3 times a day. Changes of blood lipid and clinical symptom were observed after treatment for 4 weeks. Results Compared with the control group, after patients had been treated with Tongxinluo Capsule for 4 weeks, sinificant improvement was shown in lipid abnormality.The levels of total cholesterol,riglyceride,low density lipoprotein cholesterol,apo- lipoprotein B (ApoB), lipoprotein(a),lowered and ApoA/ApoB ratio increased observiously. The effect of both remedies in elevating HDL - C was similar. Conclusion Tongxinluo Capsule had definite regulatory effect on the blood lipids and lipoproteins in patients with coronary disease and hyperlipoproteinemia

Key concepts: Medicine, Capsule, Blood lipids, Internal medicine, Apolipoprotein B, Lipoprotein, Basal (medicine), Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Eeffect of Tongxinluo Capsule on Blood Lipid in Patients with Coronary Disease — Research Paper | ScholarLens